These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24350240)

  • 1. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?
    Heyman SN; Rosenberger C; Rosen S; Khamaisi M
    Biomed Res Int; 2013; 2013():123589. PubMed ID: 24350240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches.
    Kusirisin P; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2020 Oct; 18(1):400. PubMed ID: 33081797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of contrast-induced nephropathy].
    Cousin F; Moïse M; Ilbert C; Meunier P; Jouret F
    Rev Med Liege; 2024 Jun; 79(5-6):418-423. PubMed ID: 38869133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy: pathophysiology and preventive strategies.
    Jorgensen AL
    Crit Care Nurse; 2013 Feb; 33(1):37-46. PubMed ID: 23377156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiographic contrast nephropathy].
    Andreucci M
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox.
    Li X; Li T; Cong H
    Cardiovasc Ther; 2012 Oct; 30(5):273-6. PubMed ID: 21884031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus.
    Pflueger A; Abramowitz D; Calvin AD
    Med Sci Monit; 2009 Jun; 15(6):RA125-36. PubMed ID: 19478716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of contrast-induced nephropathy.
    Wong PC; Li Z; Guo J; Zhang A
    Int J Cardiol; 2012 Jul; 158(2):186-92. PubMed ID: 21784541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy.
    Heyman SN; Rosenberger C; Rosen S
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i6-11. PubMed ID: 15705946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI).
    Vlachopanos G; Schizas D; Hasemaki N; Georgalis A
    Curr Pharm Des; 2019; 25(44):4642-4647. PubMed ID: 31820694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of contrast medium-induced nephropathy.
    Persson PB; Hansell P; Liss P
    Kidney Int; 2005 Jul; 68(1):14-22. PubMed ID: 15954892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
    Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
    Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast medium-induced nephropathy: the pathophysiology.
    Persson PB; Tepel M
    Kidney Int Suppl; 2006 Apr; (100):S8-10. PubMed ID: 16612403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk markers for contrast-induced nephropathy.
    Toprak O
    Am J Med Sci; 2007 Oct; 334(4):283-90. PubMed ID: 18030185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia.
    Heyman SN; Reichman J; Brezis M
    Invest Radiol; 1999 Nov; 34(11):685-91. PubMed ID: 10548380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors.
    Andreucci M; Faga T; Pisani A; Sabbatini M; Russo D; Michael A
    ScientificWorldJournal; 2014; 2014():823169. PubMed ID: 25525625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucagon-like peptide-1 receptor agonist Exendin-4, ameliorates contrast-induced nephropathy through suppression of oxidative stress, vascular dysfunction and apoptosis independent of glycaemia.
    Hussien NI; Sorour SM; El-Kerdasy HI; Abdelrahman BA
    Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):808-818. PubMed ID: 29637584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy.
    Pisani A; Riccio E; Andreucci M; Faga T; Ashour M; Di Nuzzi A; Mancini A; Sabbatini M
    Biomed Res Int; 2013; 2013():868321. PubMed ID: 24459673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.